BenOra Imaging

BenOra Imaging is a clinical-stage biotechnology company based in Jerusalem, Israel, that specializes in the development of novel radiopharmaceuticals for molecular imaging. The company focuses on creating Positron Emission Tomography (PET) tracers that target specific genetic mutations and biomarkers in oncology, such as EGFR mutations in non-small cell lung cancer. By providing real-time, non-invasive visualization of tumor characteristics, BenOra's technology aims to improve patient selection for targeted therapies and monitor treatment response. Their pipeline includes tracers designed to identify resistance mechanisms in cancer, facilitating a more personalized approach to oncology care. The company's research is closely integrated with the Hadassah Medical Center, leveraging advanced radiochemistry to address unmet needs in precision medicine.